Supporting effective local, state, and tribal responses to illicit substance use and misuse in order to reduce overdose deaths, promote public safety, and support access to treatment and recovery services in the criminal justice system.
Event
The National Prescription Drug Take Back Day addresses a crucial public safety and public health issue. The 2019 National Survey on Drug Use and Health shows that 9.7 million people misused prescription pain relievers, 4.9 million people misused prescription stimulants, and 5.9 million people misused prescription tranquilizers or sedatives in 2019–and a majority of misused prescription drugs were obtained from family and friends. The DEA’s Take Back Day events offer an opportunity to prevent drug addiction and overdose deaths. Learn more at https://takebackday.dea.gov/.
Funding Opportunity
The Comprehensive Opioid, Stimulant, and Substance Abuse Site-based Program FY2021 Competitive Grant Solicitation is coming soon and will be posted on the Current Funding Opportunities page when available.
Webinar
BJA leadership—in collaboration with the COSSAP team and Altarum—invites you to this no-cost webinar to be held on April 28, 2021, at 1:00 p.m., ET. Learn more about this and other webinars at https://www.cossapresources.org/Learning/Online.
Webinar
BJA leadership—in collaboration with the COSSAP team and TASC's Center for Health and Justice—invites you to this no-cost webinar to be held on April 22, 2021, at 2:00 p.m., ET. Learn more about this and other webinars at https://www.cossapresources.org/Learning/Online.
Press Release
WSYR-TV reports on a new dashboard showcasing public-facing data that tracks key information about drug overdoses and trends in Oneida County, New York. View the news report here.
Press Release
The Office of National Drug Control Policy (ONDCP) announces the largest-ever award of baseline funding to its High Intensity Drug Trafficking Areas (HIDTA) Program. The funding includes a historic expansion of the innovative Overdose Response Strategy (ORS), which brings together drug intelligence officers and public health analysts at the local and regional level to share information and develop intervention and support services that reduce overdoses. The ORS will now extend to all 50 states, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands. Read more here.
